BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Gentium S.p.A. 



Como      Italy
Phone: N/A Fax:


SEARCH JOBS


Industry
Biotechnology






 Company News
Gentium S.p.A. Announces Decision To Voluntarily Delist American Depositary Shares From The NASDAQ Global Market 3/6/2014 9:30:19 AM    More...
Jazz Pharmaceuticals plc (JAZZ) Completes Tender Offer For Gentium S.p.A. Shares 2/21/2014 9:11:05 AM    More...
Jazz Pharmaceuticals plc (JAZZ) Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares 1/23/2014 11:07:56 AM    More...
Gentium S.p.A. Shareholders Sue Over $1 Billion Jazz Pharmaceuticals plc (JAZZ) Deal 1/17/2014 7:21:23 AM    More...
Jazz Pharmaceuticals plc (JAZZ) Pays A Whopping $1 Billion For Rare Disease Drug Developer Gentium S.p.A. 12/20/2013 6:29:02 AM    More...
Interim Results From Gentium S.p.A.'s Treatment IND For Defibrotide And Additional Data On Defibrotide In The Prevention Of Acute Graft Versus Host Disease (Agvhd) Presented At The American Society of Hematology Annual Meeting 12/11/2013 7:53:03 AM    More...
Gentium S.p.A. Release: Data From Non HSCT VOD Patients Treated With Defibrotide And A Treatment IND Update To Be Presented At The American Society of Hematology 2013 Annual Meeting 11/26/2013 9:52:09 AM    More...
Gentium S.p.A. Receives European Medicines Agency Orphan Drug Designation For Defibrotide For The Prevention Of GvHD 11/19/2013 9:11:12 AM    More...
Gentium S.p.A. Announces Successful Completion Of Defibrotide Phase 1 Study In Japan 11/12/2013 12:55:15 PM    More...
Gentium S.p.A. Reports Third Quarter 2013 Financial Results 10/31/2013 10:04:37 AM    More...
12345678910...

//-->